Yasue Tsukishiro

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial

Takahiro Sawada, Hideo Tsubata, Naoko Hashimoto et al. · Cardiovascular Diabetology · 2016 · 101 citations · Full text

Longitudinal strain combined with delayed-enhancement magnetic resonance improves risk stratification in patients with dilated cardiomyopathy

Misato Chimura, Tetsuari Onishi, Yasue Tsukishiro et al. · Heart · 2016 · 68 citations

Impact of esophageal temperature monitoring guided atrial fibrillation ablation on preventing asymptomatic excessive transmural injury

Kunihiko Kiuchi, Katsunori Okajima, Akira Shimane et al. · Journal of Arrhythmia · 2015 · 24 citations · Full text

Accuracy of Nonstenotic Coronary Atherosclerosis Assessment by Multi-Detector Computed Tomography

Tetsuya Hara, Shinichiro Yamada, Takatoshi Hayashi et al. · Circulation Journal · 2007 · 18 citations · Full text

Diagnosis, Plaque Burden, Coronary Artery Disease +19